Josh Mandel-Brehm

Insider Reports History

Location
Toronto, Ontario, Canada
Signature
/s/ Kelly Gold, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Josh Mandel-Brehm:

Company Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp Chief Executive Officer, Director Common Stock 278,417 $459,388 $1.65 11 Sep 2025 Direct
Camp4 Therapeutics Corp Chief Executive Officer, Director Stock Option (Right to Buy) 425,000 11 Dec 2025 Direct
ProMIS Neurosciences Inc. Director Option (right to buy) 20,000 12 Jun 2025 Direct

Insider Reports Filed by Josh Mandel-Brehm

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 11 Dec 2025 1 $0 4 Chief Executive Officer, Director 22 Dec 2025, 17:41
CAMP Camp4 Therapeutics Corp 11 Sep 2025 1 +$9,999 4 Chief Executive Officer, Director 11 Sep 2025, 16:23
PMN ProMIS Neurosciences Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 17:23
CAMP Camp4 Therapeutics Corp 01 Apr 2025 1 $0 4 Chief Executive Officer, Director 03 Apr 2025, 16:06
CAMP Camp4 Therapeutics Corp 15 Oct 2024 2 $0 4 Chief Executive Officer, Director 15 Oct 2024, 17:45
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Chief Executive Officer, Director 10 Oct 2024, 21:06
PMN ProMIS Neurosciences Inc. 03 Oct 2024 1 $0 4 Director 07 Oct 2024, 18:38
PMN ProMIS Neurosciences Inc. 07 Jul 2022 0 $0 3 Director 07 Jul 2022, 19:26